✦ LIBER ✦

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies

✍ Scribed by Maarten J. Deenen, Heinz-Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Mariette J. Weterman, Jos H. Beijnen, Jan H. M. Schellens, Johanna W. Wilmink

Book ID: 113064567
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 299 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9723-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and pharmacokinetics of paclitaxe

Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours

✍ Campone, M; Levy, V; Bourbouloux, E; Berton Rigaud, D; Bootle, D; Dutreix, C; Zo 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

359 Phase Ib and pharmacokinetic studies

359 Phase Ib and pharmacokinetic studies of Everolimus (RAD001), a novel oral mTOR-inhibitor, with paclitaxel in patients with advanced solid tumors

✍ M. Campone; V. Levy; V. Delecroix; E. Bourbouloux; D. Bootle; C. Tanaka; N. Shan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Phase I and pharmacokinetic study of das

Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies

✍ Athanassios Argiris, Trevor M. Feinstein, Lin Wang, Tianbing Yang, Shruti Agrawa 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 460 KB

The oral mTOR inhibitor RAD001 (everolim

The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics

✍ Ahmad Awada; Fatima Cardoso; Christel Fontaine; Luc Dirix; Jacques De Grève; Chr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Phase I safety, pharmacokinetic, and pha

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors

✍ Markman, B.; Tabernero, J.; Krop, I.; Shapiro, G. I.; Siu, L.; Chen, L. C.; Mita 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 362 KB

Phase I study for ridaforolimus, an oral

Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors

✍ Yoshitaka Seki; Noboru Yamamoto; Yosuke Tamura; Yasushi Goto; Takashi Shibata; M 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 324 KB